This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Eisai R&d Management Co., Ltd., Ucl Business Plc. Active years: 2019-2023.
Company Filing History:
3 out of 530 
3 out of 299 
Years Active: 2019-2023
Title: Hirofumi Aoyagi: Innovator in Anti-Tau Antibodies
Introduction
Hirofumi Aoyagi is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target Tau proteins. His work has implications for understanding and treating neurodegenerative diseases.
Latest Patents
Hirofumi Aoyagi holds 3 patents. His latest patents include "Anti-Tau antibodies and uses thereof," which provides antibodies that specifically bind Tau and methods of using the same. This innovation is crucial for advancing therapeutic strategies against Tau-related pathologies.
Career Highlights
Throughout his career, Aoyagi has worked with prominent organizations, including Eisai R&D Management Co., Ltd. and UCL Business Plc. His experience in these companies has allowed him to refine his expertise in antibody development and research.
Collaborations
Aoyagi has collaborated with notable individuals in his field, including James Martin Staddon and Hettihewage Alfred Rohan De Silva. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Hirofumi Aoyagi's work in developing anti-Tau antibodies showcases his commitment to advancing medical science. His contributions are vital for future research and potential treatments for neurodegenerative diseases.